Advertisement

Urogenital Diseases

  • Jawahar L. Tiwari
  • Paul I. Terasaki

Abstract

Shornick et al.1 observed a significantly increased frequency of DR3 in 26 American Caucasian patients (Table 14.1). Similarly, in a small sample of 8 Spanish patients studied by Ferrando et al.2 6 (75%) were positive for DR3. The frequency of this antigen in the control population of unknown size was 14.8%.

Keywords

Population Association Tissue Antigen Idiopathic Membranous Nephropathy Balkan Endemic Nephropathy Locus Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shornick JK, Stastny P, Gilliam JN: High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestationis. J Clin Invest 68:553–555, 1981PubMedGoogle Scholar
  2. 2.
    Ferrando J, Arriaga F, Bordas X, Ercilla G, Vives J, Mascaro JM: Association of HLA-DR3 and Herpes gestationis. Acta Dermatol Venereol (Stockh) 61:462, 1981Google Scholar
  3. 3.
    Reunala T, Karvonen J, Tiilikainen A, Salo OP: Herpes gestationis. Br J Dermatol 96:563–568, 1977PubMedGoogle Scholar
  4. 4.
    Eberst E, Tongio MM, Eberst B, Mayer S, Basset A: Herpes gestationis and anti-HLA immunization. Br J Dermatol 104:553–559, 1981PubMedGoogle Scholar
  5. 1.
    Muravieva LI, Volkova LS, Chen RI: Study of the human leucocyte antigen system in married couples in disturbed reproduction. Akush Ginekol (Mosk) 8:41–43, 1979Google Scholar
  6. 2.
    Gerencer M, Kastelan A, Drazancic A, Kerhin-Brkljacic V, Madharic M: The HLA antigens in women with recurrent abnormal pregnancies of unknown etiology. Tissue Antigens 12:223–227, 1978PubMedGoogle Scholar
  7. 3.
    Gerencer M, Drazancic A, Kuvacic I, Tomaskovie Z, Kastelan A, et al.: HLA antigen studies in women with recurrent gestational disorders. Fértil Steril 31:401–404, 1979PubMedGoogle Scholar
  8. 4.
    Carapella-De Luca E, Purpura M, Coghi I, Nicotra M, Bottini E: Blood groups and histocompatibility antigens in habitual abortion. Haematologia 13:105–111, 1980PubMedGoogle Scholar
  9. 5.
    Purpura M, Coghi I, Nicotra M, Carapella E, Bottini E: HLA Bw35 antigen and human reproduction. J Med Genet 17:157–158, 1980PubMedGoogle Scholar
  10. 6.
    Lauritsen JG, Jorgensen J, Kissmeyer-Nielsen F: Significance of HLA and blood-group incompatibility in spontaneous abortion. Clin Genet 9:575–582, 1976PubMedGoogle Scholar
  11. 7.
    Schacter B, Gyves M, Muir A, Tasin M: HLA-A,B compatibility in parents of offspring with neuraltube defects or couples experiencing involuntary fetal wastage. Lancet i:796–799, 1979Google Scholar
  12. 8.
    Komlos L, Zamir R, Joshua H, Halbrecht I: Common HLA antigens in couples with repeated abortions. Clin Immunol Immunopathol 7:330–335, 1977PubMedGoogle Scholar
  13. 9.
    Beer AE, Quebbeman JF, Ayers JWT, Haines RF: Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 141:987–999, 1981PubMedGoogle Scholar
  14. 10.
    Tsuji K, Miyamoto H, Motoaki I. HL-A and its clinical application. Keio J Med 21:159–169, 1972PubMedGoogle Scholar
  15. 11.
    Lappe M: HLA homozygosity and neuraltube defects. Lancet i: 1342, 1979Google Scholar
  16. 12.
    Hull P: HLA incompatibility, genetic diversity, and survival. Lancet ii:933–934, 1981Google Scholar
  17. 13.
    Komlos L, Halbrecht I: Repeated abortions and histocompatibility antigens — can HLA antigen restricted gene dose effects influence the feto-maternal relationship? Med Hypotheses 5:901–908, 1979PubMedGoogle Scholar
  18. 14.
    Eberst B, Schumacher JC, Tongio MA, Walch R, Ritter J, Gandar R: Immunisation foeto-maternelle anti-HLA et pathologie gravidique et/ou neo-natale. J Gyn Obstet Biol Reprod (Paris) 7:57–62, 1978Google Scholar
  19. 15.
    Smith RT: The immunobiology of abortion. N Engl J Med 295:1249–1250, 1976PubMedGoogle Scholar
  20. 16.
    Gelabert A, Balasch J, Ercilla G, Vanrell JA, Vives J, Gonzalez-Merlo J, et al.: Abortion may sensitize the mother to HLA antigens. Tissue Antigens 17:353–356, 1981PubMedGoogle Scholar
  21. 17.
    Beer AE, Quebbeman JF, Ayers JWT, Haines RF: Discussion. Am J Obstet Gynecol 143:177–178, 1982Google Scholar
  22. 18.
    Patullo RA: Histocompatibility antigens in pregnancy, abortions, infertility, preeclampsia and trophoblast neoplasms. Am J Reprod Immunol 1:29–34, 1980Google Scholar
  23. 1.
    Scott JR, Beer AE, Stastny P: Immunogenetic factors in preeclampsia and eclampsia: Erythrocyte, histocompatibility, and y-dependent antigens. JAMA 235:402–404, 1976PubMedGoogle Scholar
  24. 2.
    Anichkova SI, Vasilieva ZF, Grigorieva VV: Study of compatibility in married couples according to the HLA antigen system in normal and complicated by late toxemia pregnancy. Akush Ginekol 8:20–23, 1981Google Scholar
  25. 1.
    Scott JR, Beer AE, Stastny P: Immunogenetic factors in preeclampsia and eclampsia: Erythrocyte, histocompatibility, and y-dependent antigens. JAMA 235:402–404, 1976PubMedGoogle Scholar
  26. 2.
    Jenkins DM, Need J, Rajah SM: Deficiency of specific HLA antibodies in severe pregnancy pre-eclampsia/eclampsia. Clin Exp Immunol 27:485–486, 1977PubMedGoogle Scholar
  27. 3.
    Jenkins DM, Need JA, Scott JS, Morris H, Pepper M: Human leucocyte antigens and mixed lymphocyte reaction in severe pre-eclampsia. Br Med J 1:542–544, 1978PubMedGoogle Scholar
  28. 4.
    Redman CWG, Bodmer JG, Bodmer WF, Beilin LJ, Bonnar J: HLA antigens in severe pre-eclampsia. Lancet ii:397–399, 1978Google Scholar
  29. 5.
    Simon P, Fauchet R, Menault M, Bombail D, Lefiblec B, Panguy E, et al.: HLA A, B, and DR antigens in pre-eclampsia: Preliminary results. Kidney Int 17:705–706, 1980Google Scholar
  30. 6.
    Pattillo RA: Histocompatibility antigens in pregnancy, abortions, infertility, preeclampsia and trophoblast neoplasms. Am J Reprod Immunol 1:29–34, 1980PubMedGoogle Scholar
  31. 7.
    Anichkova SI, Vasilieva ZF, Grigorieva VV: Study of compatibility in married couples according to the HLA antigen system in normal and complicated by late toxemia pregnancy. Akush Ginekol 8:20–23, 1981Google Scholar
  32. 1.
    Kamidono S, Matsumoto O, Ishigami J, Nakao Y, Tsuji K: Infertility and HLA antigen: Male infertility and infertile couples. Andrologia 12:317–322, 1980PubMedGoogle Scholar
  33. 2.
    Lindblom JB, Friberg J, Hogman CF, Gemzell C: HL-A haplotypes and unexplained infertility. Tissue Antigens 2:352–358, 1972PubMedGoogle Scholar
  34. 3.
    Malzer VG, Freistedt B, Berge H, Felker A, Hentschel W: Bereichert das HLA-System unsere Moglichkeiten im Rahmen der sterilitats-Diagnostik? Zentralbl Gynakol 101:72–74, 1979PubMedGoogle Scholar
  35. 4.
    Purpura M, Coghi I, Nicotra M, Carapella E, Bottini E: HLA Bw35 antigen and human reproduction. J Med Genet 17:157–158, 1980PubMedGoogle Scholar
  36. 5.
    Pattillo RA: Histocompatibility antigens in pregnancy, abortions, infertility, preeclampsia and trophoblast neoplasms. Am J Reprod Immunol 1:29–34, 1980PubMedGoogle Scholar
  37. 1.
    Willscher MK, Cwazka WF, Novicki DE: The association of histocompatibility antigens of the B7 cross-reacting group with Peyronie’s disease. J Urol 122:34–35, 1979PubMedGoogle Scholar
  38. 2.
    Leffell MS, Devine CJ, Horton CE, Somers KD, Dawson D, Vande Berg JS, et al: Non-association of Peyronie’s disease with HLA B7 cross-reactive antigens. J Urol 127:1223–1224,1982PubMedGoogle Scholar
  39. 3.
    Nyberg LM, Bias WB, Hochberg MC, Walsh P: Identification of an inherited form of Peyronie’s disease with autosomal dominant inheritance and association with Dupuytren’s contracture and HLA-B7 cross-reacting antigens. J Urol 128:48–51, 1982PubMedGoogle Scholar
  40. 1.
    Lassus A, Tiilikainen A, Stubb S, Reunala T, Johansson E: Circinate erosive balanitis and HL-A 27. Acta Dermatov 55:199–201, 1975Google Scholar
  41. 1.
    Sengar DPS, Rashid A, Wolfish NM: Familial urinary tract anomalies: Association with the major histocompatibility complex in man. J Urol 121:194–197, 1979PubMedGoogle Scholar
  42. 2.
    Sengar DPS, Rashid A, Wolfish NM: Histocompatibility antigens and urinary abnormalities. Br Med J 1:1146, 1978PubMedGoogle Scholar
  43. 1.
    Kamidono S, Matsumoto O, Ishigami J, Nakao Y, Tsuji K: Infertility and HLA antigen: Male infertility and infertile couples. Andrologia 12:317–322, 1980PubMedGoogle Scholar
  44. 2.
    Mueller-Eckhardt G, Krause W, Schierke G, Mueller-Eckhardt C: Male infertility due to idiopathic disorders of spermatogenesis: No association with HLA. Tissue Antigens 20:270–273, 1982PubMedGoogle Scholar
  45. 1.
    Bailey RR, Wallace M: HLA-B12 as a genetic marker for vesicoureteric reflux. Br Med J 1:48–49, 1978PubMedGoogle Scholar
  46. 2.
    Torres VE, Moore SB, Kurtz SB, Offord KP, Kelalis PP: In search of a marker for genetic susceptibility to reflux nephropathy. Clin Nephrol 14:217–222, 1980PubMedGoogle Scholar
  47. 3.
    Sengar DPS, Rashid A, Wolfish NM: Histocompatibility antigens and urinary abnormalities. Br Med J 1:1146, 1978PubMedGoogle Scholar
  48. 4.
    Sengar DPS, Rashid A, Wolfish NM: Familial urinary tract anomalies: Association with the major histocompatibility complex in man. J Urol 121:194–197, 1979PubMedGoogle Scholar
  49. 1.
    Fauchet R, Gueguen M, Genetet B, Pogamp PL, Ramee MP, Chevet D, et al: HLA-DR antigen and IgA nephropathy (Berger’s disease). N Engl J Med 302:1033–1034, 1980PubMedGoogle Scholar
  50. 2.
    Bignon JD, Houssin A, Soulillou JP, Denis J, Guimbretiere J, Guenel J: HLA antigens and Berger’s disease. Tissue Antigens 16:108–111, 1980PubMedGoogle Scholar
  51. 3.
    Le Petit JC, Cases MH, Berthoux FC, Van Loghem E, Goguen J, Seger J, et al: Genetic investigation in mesangial IgA nephropathy. Tissue Antigens 19:108–114, 1982PubMedGoogle Scholar
  52. 4.
    Brettle R, Peters DK, Batchelor JR: Mesangial IgA glomerulonephritis and HLA antigens. N Engl J Med 299:200, 1978PubMedGoogle Scholar
  53. 5.
    Komori K, Nose Y, Inouye H, Tsuji K, Nomoto Y, Sakai H: Study on HLA system in IgA nephropathy. Tissue Antigens 14:32–36, 1979PubMedGoogle Scholar
  54. 6.
    Chan Sh, Ku G, Sinniah R: HLA and Chinese IgA mesangial glomerulonephritis. Tissue Antigens 17:351–352, 1981PubMedGoogle Scholar
  55. 7.
    Sabatier JC, Genin C, Assenat H, Colon S, Ducret F, Berthoux FC: Mesangial IgA glomerulonephritis in HLA-identical brothers. Clin Nephrol 11:35–38, 1979PubMedGoogle Scholar
  56. 8.
    Katz A, Karanicolas S, Falk JA: Family study in IgA nephritis: The possible role of HLA antigens. Transplantation 29:505–506, 1980PubMedGoogle Scholar
  57. 9.
    Houssin A, Bignon JD, Soulillou JP, Guimbretiere J, Guenel J: HLA phenotypes in Berger’s disease. Kidney Int 17:702–703, 1980Google Scholar
  58. 10.
    Pogamp PL, Fauchet R, Ramee MP: HLA-DRW4 antigen and IgA-nephropathy (Berger’s disease). Eur J Clin Invest 10:29, 1980Google Scholar
  59. 11.
    Richman AV, Mahoney JJ, Fuller TJ: Higher prevalence of HLA-B12 in patients with IgA nephropathy. Ann Intern Med 90:201, 1979PubMedGoogle Scholar
  60. 12.
    Nagy J, Hamori A, Ambrus M, Hernadi E: More on IgA glomerulonephritis and HLA antigens. N Engl J Med 300:92, 1979PubMedGoogle Scholar
  61. 13.
    Noel LH, Descamps B, Jungers P, Bach JF, Bussom M, Suet C, et al: HLA antigens in three types of glomerulonephritis. Clin Immunol Immunopathol 10:19–23, 1978PubMedGoogle Scholar
  62. 14.
    Savi M, Neri TM, Silvestri MG, Allegri L, Migone L: HLA antigens and IgA mesangial glomerulonephritis. Clin Nephrol 12:45–46, 1979PubMedGoogle Scholar
  63. 15.
    Arnaiz-Villena A, Gonzalo A, Mampaso F, Teruel JL, Ortunno J: HLA and IgA nephropathy in Spanish population. Tissue Antigens 17:549–550, 1981PubMedGoogle Scholar
  64. 16.
    O’Neill S, Walker F, Spencer S, O’Dwyer WF: HLA status in IgA nephropathy. Irish J Med Sci 150:113–115, 1981PubMedGoogle Scholar
  65. 17.
    Mustonen J, Pasternack A, Helin H, Rilva A, Penttinen K, Wager O, et al: Circulating immune complexes, the concentration of serum Ig A and the distribution of HLA antigens in Ig A nephropathy. Nephron 29:170–175, 1981PubMedGoogle Scholar
  66. 18.
    Berthoux FC, Gagne A, Sabatier JC, Ducret F, Le Petit SC, Marceliin M, et al: HLA-BW35 and mesangial Ig A glomerulonephritis. N Engl J Med 298:1034–1035, 1978PubMedGoogle Scholar
  67. 19.
    Hiki Y, Kobayashi Y, Tateno S, Sada M, Kashiwagi N: Strong association of HLA-DR4 with benign IgA nephropathy. Nephron 32:222–226, 1982PubMedGoogle Scholar
  68. 20.
    Kashiwabara H, Shishido H, Tomura S, Tuchida H, Miyajima T: Strong association between IgA nephropathy and HLA-DR4 antigen. Kidney Int 22:377–382, 1982PubMedGoogle Scholar
  69. 21.
    Kashwabara H, Shishido H, Yokoyama T, Miyajima T: HLA in IgA nephropathy. Tissue Antigens 16:411–412, 1980PubMedGoogle Scholar
  70. 22.
    Fauchet R, Le Pogamp P, Genetet B, Chevet D, Gueguen M, Simon P, et al: HLA-DR4 antigen and IgA nephropathy. Tissue Antigens 16:405–410, 1980PubMedGoogle Scholar
  71. 23.
    Kasahara M, Hamada K, Okuyama T, Ishikawa N, Ogasawara K, Dceda H, et al: Role of HLA in IgA nephropathy. Clin Immunol Immunopathol 25:189–195, 1982PubMedGoogle Scholar
  72. 1.
    Patel R, Mickey MR, Terasaki PI: Leukocyte antigens and disease: I. Association of HL-A2 and chronic glomerulonephritis. Br Med J 2:424–426, 1969PubMedGoogle Scholar
  73. 2.
    Mickey MR, Kreisler M, Terasaki PI: Leukocyte antigens and disease. II. Alterations in frequencies of haplotypes associated with chronic glomerulonephritis. In Terasaki PI (ed): Histocompatibility Testing 1970. Munksgaard, Copenhagen, 1970, pp 237–242Google Scholar
  74. 3.
    Jensen H, Ryder LP, Staub Nielsen L, Clausen E, Jorgensen F, Elif Jorgensen H: HLA antigens and glomerulonephritis. Tissue Antigens 6:368–369, 1975Google Scholar
  75. 4.
    Nyulassy S, Buc M, Sasinka M, Pavlovic M, Slugen I, Hirschova V, et al.: The HLA system in glomerulonephritis. Clin Immunol Immunopathol 7:319–323, 1977PubMedGoogle Scholar
  76. 5.
    De Mouzon-Cambon A, Ohayon E, Bouissou F, Barthe P: HLA-DR typing in children with glomerular diseases. Lancet ii:868, 1980Google Scholar
  77. 6.
    Stefanova S, Andreev IG: HLA system and renal diseases. Ind J Exp Biol 18:282–284, 1980Google Scholar
  78. 1.
    Read SE, Reid H, Poon-King T, Fischetti VA, Zabriskie JB, Rapaport FT: HLA and predisposition to the nonsuppurative sequelae of group A streptococcal infections. Transplant Proc 9:543–546, 1977PubMedGoogle Scholar
  79. 2.
    Sasazuki T, Hayase R, Iwamoto I, Tsuchida H: HLA and acute poststreptococcal glomerulonephritis. N Engl J Med 301:1184–1185, 1979PubMedGoogle Scholar
  80. 3.
    Sasazuki T, Kaneoka H, Ohta N, Hayase R, Iwamoto I: Common HLA haplotypes and their association with diseases in the Japanese population. Transplant Proc 11:1871–1873, 1979PubMedGoogle Scholar
  81. 4.
    Layrisse Z, Rodriguez-Iturbe B, Garcia-Ramirez R, Rodriguez A, Tiwari J: Family studies of the HLA system in acute post-streptococcal glomerulonephritis. Hum Immunol 7:177–185, 1983PubMedGoogle Scholar
  82. 5.
    Rodriguez-Iturbe B, Moreno-Fuenmayor H, Rubio L, Garcia R, Layrisse Z: Mendelian recessive ratios in acute poststreptococcal glomerulonephritis. Exper-ientia (in press)Google Scholar
  83. 1.
    Klouda PT, Acheson EJ, Goldby FS, Lawler W, Manos J, Dyer PA, et al.: Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet ii:770–771, 1979Google Scholar
  84. 2.
    Dyer PA, Klouda PT, Harris R, Mallick NP: Properdin factor B alleles in patients with idiopathic membranous nephropathy. Tissue Antigens 15:505–507, 1980PubMedGoogle Scholar
  85. 3.
    Davies MG, Davies PG: Dermatitis herpetiformis, glomerulonephritis, and HLA-DRW3. Lancet ii:911, 1979Google Scholar
  86. 4.
    Le Petit JC, Laurent B, Berthoux FC: HLA-DR3 and idiopathic membranous nephritis (IMN) association. Tissue Antigens 20:227–228, 1982PubMedGoogle Scholar
  87. 5.
    Garavoy MR: Idiopathic membranous glomerulonephritis: An HLA-associated disease. In Terasaki PI (ed): Histocompatibility Testing 1980. UCLA Tissue Typing Laboratory, Los Angeles, 1981, pp 673–680Google Scholar
  88. 6.
    Muller GA, Muller C, Liebau G, Kompf J, Ising H, Wernet P: Strong association of idiopathic membranous nephropathy (IMN) with HLA-DR3 and MT-2 without involvement of HLA-B18 and no association to BfFl. Tissue Antigens 17:332–337, 1981PubMedGoogle Scholar
  89. 1.
    Minev M, Mikhaylov T, Kastelan A, Nyulassy S, Menzel G: HLA system and Balkan endemic nephropathy. Tissue Antigens 11:50–54, 1978PubMedGoogle Scholar
  90. 2.
    Stefanova S, Andreev IG: HLA system and renal diseases. Indian J Exp Biol 18:282–284, 1980PubMedGoogle Scholar
  91. 1.
    Nyulassy S, Buc M, Sasinka M, Pavlovic M, Slugen I, Hirschova V, et al: The HLA system in glomerulonephritis. Clin Immunol Immunopathol 7:319–323, 1977PubMedGoogle Scholar
  92. 2.
    De Mouzon-Cambon A, Bouissou F, Dutau G, Barthe Ph, Parra MT, Sevin A, et al: HLA-DR7 in children with idiopathic nephrotic syndrome. Correlation with atopy. Tissue Antigens 17:518–524, 1981PubMedGoogle Scholar
  93. 3.
    Noss G, Bachmann HJ, Olbing H: Association of minimal change nephrotic syndrome (MCNS) with HLA-B8 and B13. Clin Nephrol 15:172–174, 1981PubMedGoogle Scholar
  94. 4.
    Dippell J, Wonne R: Atopie, HLA-System und steroidsensibles nephrotisches Syndrom im Kindesalter. Monatschr Kinderheilkd 129:684–687, 1981Google Scholar
  95. 5.
    De Mouzon-Cambon A, Ohayon E, Bouissou F, Barthe P: HLA-DR typing in children with glomerular diseases. Lancet ii:868, 1980Google Scholar
  96. 6.
    Nunez-Roldan A, Vellechenous E, Fernandez-An-drade C, Martin-Govantes J: Increased HLA-DR7 and decreased DR2 in steroid-responsive nephrotic syndrome. N Engl J Med 306:366–367, 1982PubMedGoogle Scholar
  97. 1.
    Thomson PD, Barret TM, Stokes CR, Turner MW, Soothill JF: HLA antigens and atopic features in steroid-responsive nephrotic syndrome of childhood. Lancet ii:765–768, 1976Google Scholar
  98. 2.
    Thomson PD, Barrat TM, Stokes CR, Soothill JF, Turner MW: HLA typing and atopic features in steroid sensitive nephrotic syndrome of childhood. Monogr Allergy 11:60, 1977PubMedGoogle Scholar
  99. 3.
    O’Regan D, O’Callaghan U, Dundon S, Reen DJ: HLA antigens and steroid responsive nephrotic syndrome of childhood. Tissue Antigens 16:147–151, 1980PubMedGoogle Scholar
  100. 4.
    Alfiler CA, Roy LP, Doran T, Sheldon A, Bashir H: HLA-DRW7 and steroid-responsive nephrotic syndrome of childhood. Clin Nephrol 14:71–74, 1980PubMedGoogle Scholar
  101. 1.
    Descamps B, Jüngers P, Naret C, Degott C, Zingraff J, Bach JF: HLA-A1, B8-phenotype association and HB S antigenemia evolution in 440 hemodialyzed patients. Digestion 15:271–277, 1977PubMedGoogle Scholar
  102. 2.
    Bach JF, Zingraff J, Descamps B, Naret C, Jüngers P: HL-A1, 8 phenotype and HB S antigenaemia in haemodialysis patients. Lancet ii:707, 1975Google Scholar
  103. 3.
    Jüngers MP, Descamps B, Zingraff J, Naret C, Bach JF: Sur une correlation entre les antigenes d’histo-compatibilite HL-Al et 8 et une meilleure defense de l’uremique chronique contre le virus de l’hépatite B. C R Acad Sci (Paris) 281:675–678, 1975Google Scholar
  104. 4.
    Patterson MJ, Hourani MR, Mayor GH: HLA antigens and hepatitis B virus. N Engl J Med 297:1124, 1977PubMedGoogle Scholar
  105. 5.
    Hillis WD, Hillis A, Bias WB, Walker WG: Associations of hepatitis B surface antigenemia with HLA locus B specificities. N Engl J Med 296:1310–1314, 1977PubMedGoogle Scholar
  106. 6.
    Sengar DPS, Rashid A, Jindal SL, Christie CJ: HLA antigens in HBSAG infection. Vox Sang 36:353–355, 1979PubMedGoogle Scholar
  107. 7.
    Sengar DPS, McLeish WA, Sutherland M, Couture RA, Rashid A: Hepatitis B antigen (HBAG) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAG. Can Med Assoc J 112:968–971, 1975PubMedGoogle Scholar
  108. 1.
    Descamps B, Jüngers P, Naret C, Degott C, Zingraff, Bach JF: HLA-A1, B8-phenotype association and HBS antigenemia evolution in 440 hemodialyzed patients. Digestion 15:271–277, 1977PubMedGoogle Scholar
  109. 2.
    Bach JF, Zingraff J, Descamps B, Naret C, Jüngers P: HL-A1, 8 phenotype and HBS antigenaemia in haemodialysis patients. Lancet ii:707, 1975Google Scholar
  110. 3.
    Jüngers MP, Descamps B, Zingraff J, Naret C, Bach JF: Sur une correlation entre les antigenes d’histo-compatibilite HL-Al et 8 et une meilleure defense de l’uremique chronique contre le virus de l’hépatite B. C R Acad Sci (Paris) 281:675–678, 1975Google Scholar
  111. 4.
    Patterson MJ, Hourani MR, Mayor GH: HLA antigens and hepatitis B virus. N Engl J Med 297:1124, 1977PubMedGoogle Scholar
  112. 5.
    Hillis WD, Hillis A, Bias WB, Walker WG: Associations of hepatitis B surface antigenemia with HLA locus B specificities. N Engl J Med 296:1310–1314, 1977PubMedGoogle Scholar
  113. 6.
    Adorno D, Valeri M, Piazzi A, Bonini S, Papóla F, Casciani CU: Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation. Transplant Proc 11:1269–1270, 1979PubMedGoogle Scholar
  114. 1.
    Descamps B, Jungers P, Naret C, Degott C, Zingraff J, Bach JF: HLA-A1, B8-phenotype association and HBS antigenemia evolution in 440 hemodialyzed patients. Digestion 15:271–277, 1977PubMedGoogle Scholar
  115. 2.
    Bach JF, Zingraff J, Descamps B, Naret C, Jüngers P: HL-A1, 8 phenotype and HBS antigenaemia in haemodialysis patients. Lancet ii:707, 1975Google Scholar
  116. 3.
    Jüngers MP, Descamps B, Zingraff J, Naret C, Bach JF: Sur une correlation entre les antigenes d’histo-compatibilite HL-Al et 8 et une meilleure defense de l’uremique chronique contre le virus de l’hepatite B. C R Acad Sci (Paris) 281:675–678, 1975Google Scholar
  117. 4.
    Patterson MJ, Hourani MR, Mayor GH: HLA antigens and hepatitis B virus. N Engl J Med 297:1124, 1977PubMedGoogle Scholar
  118. 5.
    Hillis WD, Hillis A, Bias WB, Walker WG: Associations of hepatitis B surface antigenemia with HLA locus B specificities. N Engl J Med 296:1310–1314, 1977PubMedGoogle Scholar
  119. 6.
    Sengar DPS, Rashid A, Jindal SL, Christie CJ: HLA antigens in HBsAg infection. Vox Sang 36:353–355, 1979PubMedGoogle Scholar
  120. 7.
    Sengar DPS, McLeish WA, Sutherland M, Couture RA, Rashid A: Hepatitis B antigen (HBAG) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAG. Can Med Assoc J 112:968–971, 1975PubMedGoogle Scholar
  121. 8.
    Adorno D, Valeri M, Piazzi A, Bonini S, Papóla F, Casciani CU: Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation. Transplant Proc 11:1269–1270, 1979PubMedGoogle Scholar
  122. 1.
    Opelz G, Terasaki PI: Graft survival rates and HLA antigen frequencies in renal cadaver transplant recipients with hepatitis B antigenemia. Transplantation 25:159–160, 1978PubMedGoogle Scholar
  123. 1.
    Macurova H, Prat V, Ivaskova E: HLA antigens in polycystic kidneys. Cas Lek Cesk 118:1296–1298, 1979PubMedGoogle Scholar
  124. 2.
    Dyer PA, Watters EA, Klouda PT, Harris R, Mallick NP: Absence of linkage between adult polycystic kidney disease and the major histocompatibility system. Tissue Antigens 20:108–111, 1982PubMedGoogle Scholar
  125. 1.
    Willscher MK, Novicki DE, Cwazka WF: Association of HLA-B27 antigen with retroperitoneal fibrosis. J Urol 120:631–633, 1978PubMedGoogle Scholar
  126. 2.
    Norton JH: Idiopathic retroperitoneal fibrosis. J Urol 121:689–690, 1979PubMedGoogle Scholar
  127. 3.
    Vital Durand D, Rouhier D, Brette R: Could the HLA-B27 antigen be a predisposing factor in the development of fibrotic changes? J Urol 124:162, 1980Google Scholar
  128. 4.
    Fernandez-Herlihy L: Idiopathic retroperitoneal fibrosis and HLA-B27. J Urol 124:752, 1980PubMedGoogle Scholar
  129. 1.
    Chen WY, Hsieh BS, Yen TS, Hsia S: Histocompatibility antigen of patients with renal insufficiency tested by immune adherence. J Formosn Med Assoc 73:359–364, 1974Google Scholar
  130. 2.
    Fehrman I, Ringden O: Lymphocytes from multi-transfused uremic patients have poor MLC reactivity. Tissue Antigens 17:386–395, 1981PubMedGoogle Scholar
  131. 1.
    Migliorini P, Bombardieri S, Castellani A, Ferrara GB: HLA antigens in essential mixed cryoglobulinemia (EMC). Eur J Clin Invest 10:26, 1980Google Scholar
  132. 1.
    Sengar DPS, Rashid A, Couture RA, Schieman L, Acharya C, Wolfish NM: HLA and familial benign hematuria. Transplantation 31:310–311, 1981PubMedGoogle Scholar
  133. 1.
    Moller P, Vinje O, Fryjordet A: HLA antigens and sacro-iliitis in chronic prostatitis. Scand J Rheumatol 9:138–140, 1980PubMedGoogle Scholar
  134. 2.
    Moller P, Berg K, Vinje O: HLA phenotypes and joint affection in psoriasis, acute anterior uveitis and chronic prostatitis. Clin Genet 19:266–270, 1981PubMedGoogle Scholar
  135. 1.
    Djawari VD, Deinlein E: Zur Immunologie des Bak-terid Andrews II: HLA-Typisierung. Dermatol Monatsschr 166:305–308, 1980PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1985

Authors and Affiliations

  • Jawahar L. Tiwari
    • 1
  • Paul I. Terasaki
    • 2
  1. 1.Center for The Health SciencesUCLA Tissue Typing LaboratoryLos AngelesUSA
  2. 2.UCLA Hospital and ClinicsLos AngelesUSA

Personalised recommendations